AbbVie, Parkinson
AbbVie's Parkinson's disease drug meets main goal in late-stage trial
AbbVie's drug met the main goal in a late-stage trial when tested in patients with early Parkinson's disease, the company said on Thursday.Patients showed a statistically significant improvement when two fixed doses of the drug,
AbbVie Parkinson’s drug helps improve symptoms in late-stage study
AbbVie reported Thursday that its experimental Parkinson’s drug that it got from Cerevel Therapeutics helped alleviate symptoms and improve quality of life in a late-stage study.
AbbVie's dopamine-focused Parkinson's treatment reduces disease burden in phase 3 trial
AbbVie plans to share results from another phase 3 trial of tavapadon later this year, the pharma said in the release. That trial is testing the drug as a flexible-dose monotherapy.
AbbVie: Tavapadon Meets Primary, Secondary Endpoints In Phase 3 Trial In Early Parkinson's Disease
Drugmaker AbbVie (ABBV) announced Thursday positive topline results from its pivotal Phase 3 TEMPO-1 trial for tavapadon as a
AbbVie: Tavapadon Meets Key Endpoints in Phase 3 Parkinson's Study
AbbVie on Thursday said a late-stage study of its recently acquired tavapadon drug candidate for the neurodegenerative disorder Parkinson's disease hit its key goals. AbbVie said tavapadon met the primary endpoint in the pivotal Phase 3 fixed-dose monotherapy trial,
AbbVie Parkinson's disease therapy hits main goal in late-stage trial
AbbVie (ABBV) said its Phase 3 trial TEMPO-1 for experimental therapy Tavapadon reached main goal in Parkinson's disease. Read more here.
McKnight's Long-Term Care News2h
Promising results from Parkinson’s drug trial
Tavapadon, a drug made by AbbVie to treat Parkinson’s disease, met phase 3 TEMPO-1 trial goals treated early Parkinson's disease and improved motor skills, the company reported on Thursday.
Former NFL Star Brett Favre Reveals He Has Parkinson’s. Here’s What to Know
F ormer Green Bay Packers quarterback Brett Favre said that he has been recently diagnosed with Parkinson’s disease.
Neuroscience News2d
Parkinson’s Drug Linked to Impaired Decision-Making
Pramipexole, a Parkinson’s disease (PD) drug, impairs decision-making by hyperactivating the brain’s external globus pallidus ...
McKnight's Long-Term Care News2d
Study shows how Parkinson’s drug may impair decision-making
A new report sheds light on how a Parkinson’s disease drug may impair decision-making and lead to harmful behaviors like ...
ConsumerAffairs10h
Study: People self-treating Parkinson's with coffee without seeking medical advice
All of a sudden, the health benefits of coffee has become a hot topic. Now comes a new study that suggests people are ...
Hosted on MSN1d
Cheshire hospital patient is first to use new 'life-changing' Parkinson's drug
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Healthline8d
These Diabetes Drugs Could Help Lower Your Risk of Dementia, Parkinson’s
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...
A risky business: Why do some Parkinson's disease treatments affect decision making?
Parkinson's disease (PD), also known simply as Parkinson's, is a disorder of the nervous system that affects millions of ...
techexplorist2d
Why some Parkinson’s treatments affect decision-making
Parkinson's is caused by the loss of neurons that produce dopamine, PPX binds to dopamine receptors in the brain.
Professor Oliver Bandmann honoured for Parkinson’s research
Professor Oliver Bandmann has won the 2024 Tom Isaacs Award in recognition of his outstanding Parkinson’s research.The Tom ...